Yao Fu Shou Wins the 2026 Health Industry Innovation Enterprise Award
2026/06/06
Corporate News

Yaofushou Receives the 2026 Health Industry Innovation Enterprise Award

At the recent Third China Health Industry Summit, Yao Fu Shou was honored with the "2026 Health Industry Innovation Enterprise Award" for its outstanding innovation capabilities and superior product quality.

At the recently held 3rd China Health Industry Summit, China Yaofushou Biopharmaceutical Technology Co., Ltd. stood out among numerous participating companies and was honored with the "2026 Health Industry Innovation Enterprise Award" for its outstanding innovation capabilities and excellent product quality.

This awards program is organized by the China Health Industry Association to recognize innovative companies that have made outstanding contributions to the health industry. The judging panel consists of industry experts, scholars, and representatives from investment firms, conducting a comprehensive evaluation across multiple dimensions including technological innovation, product quality, market performance, and social responsibility.

Since its inception, Yaofushou has been dedicated to R&D and innovation in the field of sleep health. Our core product, "Yaofushou Sleep Support Tablets," leverages biopharmaceutical technology combined with natural herbal extracts to provide safe and effective sleep solutions for users worldwide.

The company's managing director stated: "This award recognizes the Yao Fu Shou team's years of dedication and encourages our commitment to innovation. Moving forward, we will continue to increase R&D investment, launch more high-quality products, and contribute to global health."

Yao Fu Shou has established industry-academia-research partnerships with multiple renowned universities, holds over 15 national patents, and serves more than 10 million users.